Department of Animal and Food Sciences, University of Kentucky, 325 Cooper Dr., Lexington, KY 40546, United States.
College of Veterinary Medicine, Lincoln Memorial University, 6965 Cumberland Gap Parkway, Harrogate, TN 37752, United States.
Res Vet Sci. 2022 Mar;143:13-19. doi: 10.1016/j.rvsc.2021.12.012. Epub 2021 Dec 20.
Due to the potential risk for cannabidiol (CBD) to negatively impact the immune system, the objective of the current study was to evaluate the effect of CBD on the canine immune response to immunization with a novel antigen, keyhole limpet hemocyanin (KLH). Thirty-two dogs (22.4 ± 6.3 kg BW) were utilized in a completely randomized design with treatments consisting of 5 mg CBD/kg BW/d and a control administered orally via treats. After a 7-d acclimation to treatments, dogs were immunized with 10 mg/dog of KLH via intramuscular injection into the semimembranosus muscle region, which was repeated in 14 d. Blood samples were collected at baseline and weekly for 28 d after initial KLH immunization for analysis of hematology, serum chemistry, and immunoglobulins. Data were analyzed using the MIXED procedure in SAS including the fixed effects of treatment, day, and the treatment by day interaction. Both primary and secondary KLH immunization produced robust immune responses. Most hematological and serum chemistry variables remained within normal reference ranges for dogs across both treatments throughout the study. Alkaline phosphatase, while within normal reference range and similar between treatments at baseline and on d 7 (P = 0.994 and 0.183, respectively), was elevated for CBD-treated dogs versus control on d 14, 21, and 28 (P = 0.006, 0.027, and 0.014, respectively). Both total and KLH-specific IgG and IgM were similar between treatments throughout the study (P > 0.05), although total IgM peaked earlier in control dogs compared to those receiving CBD. Despite the minor shift in the timing of the total IgM peak, CBD did not appear to exhibit humoral immunosuppressive effects when supplemented at 5 mg/kg BW/d. However, this work does highlight the potential for CBD to alter liver function and the need for further safety evaluations of CBD use in dogs utilizing longer-term studies and multiple CBD doses.
由于大麻二酚(CBD)可能对免疫系统产生负面影响,因此本研究的目的是评估 CBD 对犬科动物对新型抗原钥孔血蓝蛋白(KLH)免疫反应的影响。32 只犬(22.4±6.3kgBW)采用完全随机设计,处理组分为 5mg CBD/kgBW/d 和通过口服零食给予的对照组。在适应治疗 7 天后,狗通过肌肉内注射到半膜肌区域接受 10mg/dog 的 KLH 免疫接种,14 天后再次重复。在初次 KLH 免疫接种后 28 天内每周采集基线和血液样本,用于分析血液学、血清化学和免疫球蛋白。使用 SAS 中的 MIXED 程序分析数据,包括处理、天和处理与天的相互作用的固定效应。初次和二次 KLH 免疫均产生了强大的免疫反应。在整个研究过程中,大多数血液学和血清化学变量在两种治疗中均保持在犬的正常参考范围内。碱性磷酸酶在基线和第 7 天(P=0.994 和 0.183)在正常参考范围内,并且在两种治疗中相似,但 CBD 治疗犬的碱性磷酸酶在第 14、21 和 28 天高于对照组(P=0.006、0.027 和 0.014)。在整个研究过程中,总 IgG 和 KLH 特异性 IgG 和 IgM 在两种治疗之间相似(P>0.05),尽管对照组犬的总 IgM 峰值早于接受 CBD 的犬。尽管总 IgM 峰值的时间略有变化,但当以 5mg/kgBW/d 补充 CBD 时,它似乎没有表现出体液免疫抑制作用。然而,这项工作确实强调了 CBD 改变肝功能的潜力,并需要利用长期研究和多个 CBD 剂量进一步评估 CBD 在犬中的使用安全性。